Stroke and urosepsis after discontinuation of rivaroxaban

International Journal of Cardiology

Volumn 169, Issue 5, 2013, Pages

  Stöllberger, Claudia ^a   Finsterer, Josef ^a  

^a KRANKENANSTALT RUDOLFSTIFTUNG   (Austria)

Author keywords

Atrial fibrillation; Epilepsy; Infection; Rivaroxaban; Stroke

Indexed keywords

ALLOPURINOL; AMLODIPINE; BISOPROLOL; CARBAMAZEPINE; CEFTAZIDIME; CIPROFLOXACIN; ENALAPRIL; FUROSEMIDE; HYDROCHLOROTHIAZIDE; RIVAROXABAN; SIMVASTATIN;

AGED; ANTICOAGULANT THERAPY; CASE REPORT; CEREBROVASCULAR ACCIDENT; COMPUTER ASSISTED TOMOGRAPHY; DIARRHEA; DRUG WITHDRAWAL; DYSLIPIDEMIA; ENTEROCOCCUS FAECALIS; EPIDIDYMITIS; HEART ATRIUM FIBRILLATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LETTER; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; SEIZURE; THROMBOEMBOLISM; URINE CULTURE; UROSEPSIS;

ATRIAL FIBRILLATION; EPILEPSY; INFECTION; RIVAROXABAN; STROKE;

AGED, 80 AND OVER; ANTICOAGULANTS; HUMANS; MALE; MORPHOLINES; SEPSIS; STROKE; THIOPHENES; URINARY TRACT INFECTIONS;

EID: 84887993505     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.08.025     Document Type: Article

References (10)

1. M.R. Patel, K.W. Mahaffey, and J. Garg Rivaroxaban versus warfarin in nonvalvular atrial fibrillation N Engl J Med 364 2011 883 891
2. M.R. Patel, A.S. Hellkamp, and Y. Lokhnygina Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (rivaroxaban once-daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation) J Am Coll Cardiol 61 2013 651 658
3. L.M. Haynes, T. Orfeo, and K.G. Mann Rivaroxaban delivery and reversal at a venous flow rate Arterioscler Thromb Vasc Biol 32 2012 2877 2883
4. G. Chahal, A. Saithna, and M. Brewster A comparison of complications requiring return to theatre in hip and knee arthroplasty patients taking enoxaparin versus rivaroxaban for thromboprophylaxis Ortop Traumatol Rehabil 15 2013 125 130
5. S.S. Jameson, M. Rymaszewska, A.C. Hui, P. James, I. Serrano-Pedraza, and S.D. Muller Wound complications following rivaroxaban administration: a multicenter comparison with low-molecular-weight heparins for thromboprophylaxis in lower limb arthroplasty J Bone Joint Surg Am 94 2012 1554 1558
6. K. Sindali, B. Rose, H. Soueid, P. Jeer, D. Saran, and R. Shrivastava Elective hip and knee arthroplasty and the effect of rivaroxaban and enoxaparin thromboprophylaxis on wound healing Eur J Orthop Surg Traumatol 23 2013 481 486
7. D. Kubitza, M. Becka, A. Roth, and W. Mueck The influence of age and gender on the pharmacokinetics and pharmacodynamics of rivaroxaban-an oral, direct Factor Xa inhibitor J Clin Pharmacol 53 2013 249 255
8. N. Popović, M. Stefanović-Budimkić, and N. Mitrović The frequency of poststroke infections and their impact on early stroke outcome J Stroke Cerebrovasc Dis 22 2013 424 429
9. H. Sun, X. Wang, J.L. Degen, and D. Ginsburg Reduced thrombin generation increases host susceptibility to group A streptococcal infection Blood 113 2009 1358 1364
10. N. Maggio, I. Blatt, A. Vlachos, D. Tanne, J. Chapman, and M. Segal Treating seizures and epilepsy with anticoagulants? Front Cell Neurosci 7 2013 19